Navigation Links
Bound by attention: Bringing rats and humans together
Date:11/18/2008

When picking through a basket of fruit, it doesn't seem very difficult to recognize a green pear from a green apple. This is easy, thanks to "feature binding" a process by which our brain combines all of the specific features of an object and gives us a complete and unified picture of it. For example, upon first seeing the fruit basket, our brain immediately gets to work, connecting (or binding) information about each fruit's shape to its color to ensure that we select the green apple we are craving instead of a green pear. However, if our brain gets distracted, our ability for feature binding is reduced and we may inadvertently end up biting into the green pear instead. It was well known which areas of the brain are involved in feature binding, but it was unclear which neurotransmitters (or brain chemicals) contribute to this important process.

Psychologists Leigh C.P. Botly and Eve De Rosa from the University of Toronto wanted to investigate if acetylcholine is involved in feature binding. Acetylcholine is a neurotransmitter that is important for attention and seemed like a good candidate for playing a role in feature binding as well. A group of volunteers participated in a feature binding task (choosing among various shapes and colors), with some of them being distracted throughout the duration of the task. The psychologists also developed a feature binding task for rats (having them choose among variously scented food bowls) and treated some of the animals with the drug scopolamine, which temporarily blocks the effects of acetylcholine.

The results, reported in the November issue of Psychological Science, a journal of the Association for Psychological Science, showed that patterns of behavior were very similar in distracted humans and rats on scopolamine. Both the drug treated rats and distracted humans had a decreased ability to complete the feature binding task (which required the ability to combine many different features of an object together) although their ability to process just single features of an object (e.g. one specific color or odor) was not affected. In other words, blocking the rats' cholinergic system (by using scopolamine) made them behave similarly to distracted humans, suggesting that the neurotransmitter acetylcholine is necessary for feature binding to occur. The authors note that "acetylcholine may provide the attentional 'glue' for feature binding."

Their findings have important clinical implications, as the development of a better animal model of distraction and inattention may lead to improved therapies and treatments for a variety of disorders, such as Alzheimer's disease.


'/>"/>

Contact: Catherine West
cwest@psychologicalscience.org
202-293-9300
Association for Psychological Science
Source:Eurekalert

Related medicine news :

1. CVS Caremark All Kids Can Announces the Opening of a Boundless Playground in Los Angeles to Serve Children of All Abilities
2. Transplantation: molecular miscegenation blurs the boundary between self and non-self
3. Tomlinson Attributes Rebound to Anti-Inflammatory Cream
4. Hydration Will Be Key For Beijing Bound Olympians, What Every Athlete Must Know
5. Tri-anim and Bound Tree Medical Merge to Create Nations Leading Specialty Health Care Distributor
6. Racial disparities in the outcomes of patients with chronic kidney disease abound
7. Survey: Parents Let Their Own Experiences Affect Drug and Alcohol Boundaries Set for Teens at Prom and Graduation Parties
8. 2,500 Riders in AIDS/LifeCycle Set to Leave San Francisco June 1, Bound for Los Angeles, Raising a Record $11+ Million for HIV/AIDS Services
9. Lucrative Sales Opportunities Abound With Melaleuca, The Wellness Company(R)
10. CNA/NNOC Statement on Restraining Order Against SEIU: Threats, Harassment and Stalking of RNs Remain Out of Bounds
11. Breaking Boundaries Program Honors Colorectal Cancer Survivors for Outstanding Leadership Achievements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... ... The Touchpoint Solution’s new neuroscience wearable, Buzzies, generated over $100K in sales online ... $25,000 on Kickstarter to bring to the market what people are calling ... inventor, says she feels like she stumbled upon a miracle that she wants other ...
(Date:12/6/2016)... ... ... Of the variety of ingredients in the food supply, few spark more ... beliefs that hot dogs include “everything but the oink,” today’s wieners are made from ... meat and poultry in a hot dog recipe can add flavor, keep hot dogs ...
(Date:12/6/2016)... ... December 06, 2016 , ... Public middle and high schools ... apply for a 2016/2017 California Casualty Thomas R. Brown Athletics Grant. The application ... receive up to $3,000. , The grant is named after California Casualty ...
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... ... charity, is thrilled to formally announce its Not a Moment to Lose fundraising ... Lose will rally supporters dedicated to declaring victory over cancer. The campaign aims ...
(Date:12/6/2016)... ... December 06, 2016 , ... METTLER TOLEDO has ... knowledge resources, including white papers, guides, handbooks, case studies, magazines, webinars, videos, catalogs, ... more than 9,000 documents, webinars and videos available online, visit the METTLER ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016  Nearly 30 million people in ... the epidemic of diabetes. 1 However, nearly 40% ... glucose levels (hyperglycemia) and significant glucose variability. 2 These ... including cardiovascular events. If left untreated, hyperglycemia can lead ... disease or blindness. 3 As part ...
(Date:12/6/2016)... 6, 2016   Sienna Biopharmaceuticals, Inc. ... and aesthetics company, today announced it has ... pharmaceutical company focused on developing first-in-class topical ... psoriasis, atopic dermatitis and pruritus (itch). Under ... make an undisclosed upfront payment in cash ...
(Date:12/6/2016)... 6, 2016  Viking Therapeutics, Inc. ("Viking") (NASDAQ: ... focused on the development of novel therapies for ... U.S. Food and Drug Administration (FDA) has granted ... of X-linked adrenoleukodystrophy (X-ALD).  VK0214 is a novel, ... selectively regulates the expression of genes believed to ...
Breaking Medicine Technology: